Prof. Hongbo Wu | Reproductive Medicine | Best Researcher Award

Qinzhou Maternity and Child Health Hospital | China.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Wu Hongbo earned his doctorate from the prestigious Xiangya School of Medicine, Central South University, laying a robust foundation for his illustrious career in reproductive medicine. His academic training provided a unique blend of clinical expertise and a deep understanding of scientific inquiry, setting the stage for his future endeavors.

💼PROFESSIONAL ENDEAVORS

Dr. Wu began his career at the Reproductive Medical Research Center, The First Affiliated Hospital of Guangxi Medical University, where he contributed to cutting-edge clinical and scientific advancements in assisted reproductive technology (ART) from 2004 to 2019. Since April 2019, he has served as the Director of the Reproductive Medicine Center at Qinzhou Maternity and Child Health Hospital, where he continues to push the boundaries of ART to transform the lives of his patients.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON REPRODUCTIVE MEDICINE

Dr. Wu specializes in managing complex reproductive conditions, including advanced maternal age, decreased ovarian reserve, recurrent IVF failure, and recurrent miscarriage. His research emphasizes innovative treatments such as platelet-rich plasma therapy, growth hormone applications, and novel interventions for thin endometrium and diminished ovarian reserve.
Key studies include:

  • Warm Acupuncture and Platelet-Rich Plasma Therapy for endometrial improvement.
  • The role of GnRH agonists and growth hormones in enhancing implantation success rates.
  • Pioneering work on mRNA modifications in ovarian follicle development and their implications for reproductive success.

🌍IMPACT AND INFLUENCE

Dr. Wu’s leadership extends beyond clinical practice. As a member of several influential committees, including the Guangxi Human Assisted Reproductive Technology Management Committee and the Reproductive Medicine Professional Committee of the Guangxi Medical Association, he has significantly shaped reproductive health policies and practices in Guangxi and beyond.

📚ACADEMIC CITATIONS

His research has been recognized in numerous high-impact academic journals, including:

  • Journal of Nanobiotechnology
  • Microbial Cell Factories
  • MicrobiologyOpen
  • Journal of Clinical Laboratory Analysis
  • Chemical Engineering Journal
  • Talanta These publications underscore his contributions to the field of microbiology, particularly in diagnostic technologies and resistance mechanisms.

🏆RESEARCH GRANTS AND FUNDING

Dr. Wu has led and participated in multiple provincial and departmental research projects, securing funding for studies on innovative therapies like stem cell transplantation and telemedicine in ART. These projects underscore his commitment to improving outcomes for patients facing complex reproductive challenges.

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in reproductive medicine, Dr. Wu continues to advance the field through his clinical expertise, innovative research, and leadership. His focus on integrating technology, such as telemedicine systems, into ART practices exemplifies his forward-thinking approach. Dr. Wu’s work has the potential to redefine reproductive healthcare, ensuring accessibility and improved outcomes for future generations.

📑NOTABLE PUBLICATIONS

“PCBP1/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA ac4C Formation in Mammalian Cells”

Authors: Jiang, Z.-Y.; Wu, Y.-K.; Deng, Z.-Q.; Wu, H.-B.; Fan, H.-Y.
Year: 2024
Journal: Advanced Science

“SARS-CoV-2 infection negatively impacts on the quality of embryos by delaying early embryonic development”

Authors: Ma, L.; Yao, Y.; Zhang, Z.; Liu, Z.; Ma, Y..
Year: 2024
Journal: American Journal of Reproductive Immunology

“NAT10-mediated mRNA N4-acetylcytidine modifications in mouse oocytes constitute a checkpoint of ovarian follicle development”

Authors: Wang, W.-J.; Wu, Y.-K.; Liu, S.-Y.; Wu, H.-B.; Fan, H.-Y.
Year: 2024
Journal: Science Bulletin

“Administration of depot GnRH agonist prior to programmed frozen-thawed embryo transfer does not improve the live birth rate in ovulatory women: A large, multi-center retrospective study”

Authors: Wu, H.; Wei, F.; Tan, W.; Song, G.; Liu, L.
Year: 2022
Journal: Medicine (United States)

“The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis”

Authors: Yuan, L.; Wu, H.; Huang, W.; Qin, A.; Yang, Y.
Year: 2021
Journal: Reproductive Biology and Endocrinology

Prof. Hongbo Wu | Reproductive Medicine | Best Researcher Award